Stock listing
SD3 Stock Price, News, Filings & Events — Simulations Plus, Inc.
Selected listing: SD3 · GETTEX · EUR · DE
This page tracks Simulations Plus, Inc.'s SD3:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SD3:GETTEX. SD3:GETTEX is the stock-level entry point for investors researching Simulations Plus, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Simulations Plus, Inc. (Ticker: SLP) is a public company based in the United States, specializing in software and services for drug discovery and development. With a market capitalization of approximately $368.7 million, the company focuses on providing innovative solutions to enhance the efficiency of pharmaceutical research.
- Ticker
- SD3:GETTEX
- Asset type
- Stock
- Market cap
- $372.9M
- Sector
- Technology Services
- Industry
- Packaged Software
- Exchange
- GETTEX
- Currency
- EUR
Simulations Plus, Inc. SD3:GETTEX stock context
This page tracks Simulations Plus, Inc.'s SD3:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SD3:GETTEX. SD3:GETTEX is the stock-level entry point for investors researching Simulations Plus, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Simulations Plus, Inc. (Ticker: SLP) is a public company based in the United States, specializing in software and services for drug discovery and development. With a market capitalization of approximately $368.7 million, the company focuses on providing innovative solutions to enhance the efficiency of pharmaceutical research.
Latest news from Simulations Plus, Inc.
Simulations Plus Expands FDA Adoption of ADMET Predictor® with New Licenses for the Cosmetics Regulatory Science Branch
September 17, 2026
Simulations Plus Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Altaris
August 13, 2026
Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results
July 9, 2026
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
July 6, 2026
Simulations Plus Advances Agentic Drug Development with NVIDIA BioNeMo Agent Toolkit
June 23, 2026
Simulations Plus, Inc. earnings calls
Simulations Plus, Inc. (SLP) Q2 2026 Earnings Call
April 9, 2026 · Replay with transcript and chapters
Simulations Plus, Inc. (SLP) Q1 2026 Earnings Call
January 8, 2026 · Replay with transcript and chapters
Simulations Plus, Inc. (SLP) Q4 2025 Earnings Call
December 1, 2025 · Replay with transcript and chapters
Simulations Plus, Inc. (SLP) Q3 2025 Earnings Call
July 14, 2025 · Replay with transcript and chapters
Simulations Plus, Inc. (SLP) Q2 2025 Earnings Call
April 3, 2025 · Replay with transcript and chapters
Simulations Plus, Inc. (SLP) Q1 2025 Earnings Call
January 7, 2025 · Replay with transcript and chapters
Research Simulations Plus, Inc.
Simulations Plus, Inc. investor report
Review AI stock analysis and investor report context for SD3:GETTEX.
Simulations Plus, Inc. company profile
View the public company page for Simulations Plus, Inc. on 6ix.
Simulations Plus, Inc. news
Read company news and market updates connected to Simulations Plus, Inc..
Simulations Plus, Inc. investor events
Find investor webinars, events, and replay context for Simulations Plus, Inc..
Alternate listings
SLP:NASDAQ
US · USD
Alternate listing for Simulations Plus, Inc.; the primary context on this page is SD3:GETTEX.
SD3:TRADEGATE
DE · EUR
Alternate listing for Simulations Plus, Inc.; the primary context on this page is SD3:GETTEX.
SLP:BOATS
US · USD
Alternate listing for Simulations Plus, Inc.; the primary context on this page is SD3:GETTEX.
SD3:FWB
DE · EUR
Alternate listing for Simulations Plus, Inc.; the primary context on this page is SD3:GETTEX.
SD3:DUS
DE · EUR
Alternate listing for Simulations Plus, Inc.; the primary context on this page is SD3:GETTEX.
924294:LS
DE · EUR
Alternate listing for Simulations Plus, Inc.; the primary context on this page is SD3:GETTEX.
SD3:MUN
DE · EUR
Alternate listing for Simulations Plus, Inc.; the primary context on this page is SD3:GETTEX.